-
Je něco špatně v tomto záznamu ?
Frequency of selected thrombophilias in women with placental abruption
M Prochazka, M Lubusky, L Slavik, P Hrachovec, P Zielina, M Kudela, PG Lindqvist
Jazyk angličtina Země Austrálie
NLK
Wiley Online Library (archiv)
od 1997-01-01 do 2012-12-31
- MeSH
- dospělí MeSH
- faktor V genetika MeSH
- financování organizované MeSH
- habituální potrat epidemiologie MeSH
- hodnocení rizik MeSH
- lidé MeSH
- methylentetrahydrofolátreduktasa (NADPH2) genetika MeSH
- předčasné odlučování placenty epidemiologie genetika MeSH
- protrombin genetika MeSH
- rezistence k aktivovanému proteinu C epidemiologie genetika MeSH
- studie případů a kontrol MeSH
- těhotenství MeSH
- trombofilie epidemiologie genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
OBJECTIVE: There is a growing view that inherited or acquired thrombophilia may predispose a woman towards an adverse pregnancy outcome. The aim of this study was to investigate whether risk factors for placental abruption because of such thrombophilias (such as carriership of factor V Leiden (FVL), prothrombin G20210A gene mutation and homozygous MTHFR C677T) might be used as a predictor for placental abruption. METHODS: A retrospective case-control study conducted at the University Hospital, Palacky University, Olomouc, Czech Republic. One hundred and eighty women with placental abruption out of 20,175 deliveries (0.79%) were compared to 196 unselected gravidae. A detailed medical history was taken with special reference to factors related to hypercoagulation and blood was drawn for polymerase chain reaction analysis. The prevalence of FVL, prothrombin G20210A and MTHFR C677T was related to placental abruption. RESULTS: The heterozygous form of FVL was present in 20of 142 cases (14.1%) in the placental abruption group, compared to ten of 196 (5.1%) in the control group (odds ratio 3.0, 95% confidence interval 1.4-6.7). CONCLUSIONS: We found that factor V Leiden is a significant risk factor for placental abruption.
Department of Obstetrics and Gynecology Medical Faculty of Palacky University Olomouc Czech Republic
- 000
- 03123naa 2200469 a 4500
- 001
- bmc10010209
- 003
- CZ-PrNML
- 005
- 20151007115857.0
- 008
- 100429s2007 at e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a at
- 100 1_
- $a Procházka, Martin, $7 xx0019288 $d 1970-
- 245 10
- $a Frequency of selected thrombophilias in women with placental abruption / $c M Prochazka, M Lubusky, L Slavik, P Hrachovec, P Zielina, M Kudela, PG Lindqvist
- 314 __
- $a Department of Obstetrics and Gynecology, Medical Faculty of Palacky University, Olomouc, Czech Republic. martinprochazka@hotmail.com
- 520 9_
- $a OBJECTIVE: There is a growing view that inherited or acquired thrombophilia may predispose a woman towards an adverse pregnancy outcome. The aim of this study was to investigate whether risk factors for placental abruption because of such thrombophilias (such as carriership of factor V Leiden (FVL), prothrombin G20210A gene mutation and homozygous MTHFR C677T) might be used as a predictor for placental abruption. METHODS: A retrospective case-control study conducted at the University Hospital, Palacky University, Olomouc, Czech Republic. One hundred and eighty women with placental abruption out of 20,175 deliveries (0.79%) were compared to 196 unselected gravidae. A detailed medical history was taken with special reference to factors related to hypercoagulation and blood was drawn for polymerase chain reaction analysis. The prevalence of FVL, prothrombin G20210A and MTHFR C677T was related to placental abruption. RESULTS: The heterozygous form of FVL was present in 20of 142 cases (14.1%) in the placental abruption group, compared to ten of 196 (5.1%) in the control group (odds ratio 3.0, 95% confidence interval 1.4-6.7). CONCLUSIONS: We found that factor V Leiden is a significant risk factor for placental abruption.
- 650 _2
- $a habituální potrat $x epidemiologie $7 D000026
- 650 _2
- $a předčasné odlučování placenty $x epidemiologie $x genetika $7 D000037
- 650 _2
- $a rezistence k aktivovanému proteinu C $x epidemiologie $x genetika $7 D020016
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a faktor V $x genetika $7 D005165
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a methylentetrahydrofolátreduktasa (NADPH2) $x genetika $7 D042965
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a protrombin $x genetika $7 D011516
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a trombofilie $x epidemiologie $x genetika $7 D019851
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Ľubušký, Marek, $d 1970- $7 xx0073925
- 700 1_
- $a Slavík, Luděk $7 xx0081908
- 700 1_
- $a Hrachovec, Petr $7 xx0076909
- 700 1_
- $a Zielina, Petr. $7 xx0309188
- 700 1_
- $a Kudela, Milan, $d 1943- $7 jn20000710365
- 700 1_
- $a Lindqvist, Pelle G
- 773 0_
- $t Australian & New Zealand Journal of Obstetrics & Gynaecology $w MED00000623 $g Roč. 47, č. 4 (2007), s. 297-301 $x 0004-8666
- 910 __
- $a ABA008 $b x $y 8 $z 0
- 990 __
- $a 20100519121015 $b ABA008
- 991 __
- $a 20151007120042 $b ABA008
- 999 __
- $a ok $b bmc $g 724070 $s 587203
- BAS __
- $a 3
- BMC __
- $a 2007 $b 47 $c 4 $d 297-301 $i 0004-8666 $m Australian and New Zealand Journal of Obstetrics and Gynaecology $n Aust N Z J Obstet Gynaecol $x MED00000623
- LZP __
- $a 2010-B2/dkme